Inicio / Hematología / Abstracts de hematología / Diffuse large B‐cell lymphoma…

Diffuse large B‐cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment

0 / 5 (0 votos)
Diffuse large B‐cell lymphoma: 2019 update on diagnosis, risk stratification, and treatment

American Journal of Hematology

Fecha de publicación: 11 March 2019

DOI: https://doi.org/10.1002/ajh.25460

Autores: Yang Liu, Stefan Klaus Barta

Background: Diffuse large B‐cell lymphoma (DLBCL) is the most common type of aggressive non‐Hodgkin lymphoma originating from the germinal center, and it represents a heterogeneous group of diseases with variable outcomes that are differentially characterized by clinical features, cell of origin (COO), molecular features, and most recently, frequently recurring mutations.

Leer más

Comentarios

Para dejar un comentario antes debes iniciar sesión:

¿No tienes una cuenta?

Regístrate a través de éste enlace.